Endoglin Antikörper (AA 601-658)

Produktnummer ABIN670401

Zitiert in 8+ Publikationen. Der Kaninchen Polyklonal anti-Endoglin Antikörper (ABIN670401) detektiert spezifisch Endoglin in IF, IHC (fro) und IHC (p). Dieser Antikörper reagiert spezifisch mit Proben aus Human.

Kurzübersicht für Endoglin Antikörper (AA 601-658) (ABIN670401)

Target: Endoglin (ENG)

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Endoglin Antikörper ist unkonjugiert

Applikation: Immunofluorescence (IF), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Produktdetails anti-Endoglin Antikörper

Bindungsspezifität: AA 601-658

Verwendungszweck: CD105 Polyclonal Antibody

Kreuzreaktivität: Maus

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human CD105

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IHC-P(1:100-500), IHC-F(1:100-500), IF(1:100-500)

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: 0.01M TBS ( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.

Haltbarkeit: 12 months

Referenzen für anti-Endoglin Antikörper (ABIN670401)

Hussien, Ebrahim, Mohammed, Sabry: "Combination of Obestatin and Bone Marrow Mesenchymal Stem Cells Prevents Aggravation of Endocrine Pancreatic Damage in Type II Diabetic Rats." in: International journal of stem cells, Vol. 10, Issue 2, pp. 129-143, (2017) (PubMed).

Li, Cai, Yang, Zhang, Sun, Yan, Qu, Wang, Wang, Duan: "Perichondrium mesenchymal stem cells inhibit the growth of breast cancer cells via the DKK-1/Wnt/β-catenin signaling pathway." in: Oncology reports, Vol. 36, Issue 2, pp. 936-44, (2017) (PubMed).

Naderi-Meshkin, Matin, Heirani-Tabasi, Mirahmadi, Irfan-Maqsood, Edalatmanesh, Shahriyari, Ahmadiankia, Moussavi, Bidkhori, Bahrami: "Injectable hydrogel delivery plus preconditioning of mesenchymal stem cells: exploitation of SDF-1/CXCR4 axis towards enhancing the efficacy of stem cells' homing." in: Cell biology international, (2015) (PubMed).

Fan, Chen, Ni, Wang, Sun, Chen, Zheng: "Expression of MMP-1/PAR-1 and patterns of invasion in oral squamous cell carcinoma as potential prognostic markers." in: OncoTargets and therapy, Vol. 8, pp. 1619-26, (2015) (PubMed).

Tepekoy, Ozturk, Sozen, Ozay, Akkoyunlu, Demir: "CD90 and CD105 expression in the mouse ovary and testis at different stages of postnatal development." in: Reproductive biology, Vol. 15, Issue 4, pp. 195-204, (2015) (PubMed).

Boopathy, Pendergrass, Che, Yoon, Davis: "Oxidative stress-induced Notch1 signaling promotes cardiogenic gene expression in mesenchymal stem cells." in: Stem cell research & therapy, Vol. 4, Issue 2, pp. 43, (2014) (PubMed).

Gao, Zhang, Ding, Chen, Hu, Jiang, Li, Chen, Wang, Ye, Zhu: "Common expression of stemness molecular markers and early cardiac transcription factors in human Wharton's jelly-derived mesenchymal stem cells and embryonic stem cells." in: Cell transplantation, Vol. 22, Issue 10, pp. 1883-900, (2014) (PubMed).

Details zu Endoglin

Target: Endoglin (ENG)

Andere Bezeichnung: CD105

Hintergrund: Synonyms: END, Endoglin, ENG, FLJ41744, HHT1, ORW, ORW1, Osler Rendu Weber syndrome 1, RP11 228B15.2, CD 105, CD105 antigen, EGLN_HUMAN, AI528660, AI662476, S-endoglin, SN6.

Gen-ID: 2022

UniProt: P17813